Hoth Therapeutics Inc

NASDAQ:HOTH   9:38:40 AM EDT
0.82
+0.04 (+5.40%)
Products, Regulatory

Hoth Therapeutics Inks Contracts With WuXi STA To Advance Manufacturing Of Cancer Therapeutic

Published: 11/08/2021 13:50 GMT
Hoth Therapeutics Inc (HOTH) - Hoth Therapeutics Inks Api and Drug Product Contracts With Wuxi Sta to Advance Manufacturing of Ht-kit Cancer Therapeutic.
Hoth Therapeutics Inc - Ht-kit Api Process Development for Manufacturing is Already Underway, Expecting to Yield Small Scale Material in Q1 2022.
Hoth Therapeutics Inc - Intends to Develop Ht-kit As Parenteral Formulation for Injection.
Hoth Therapeutics Inc - After Completion of Formulation Development, Co Intends to Pursue a Pre-ind Meeting With US FDA.